However, Chen et al. indicated that the interaction between APOE4 and Klotho may not only provide protection of reduced AD risk and slowed progression in the early stages of the disease for APOE4 carriers, but also provide significant protection of slowed cognitive decline for non-carriers in later disease stages49. This evidence concerns the gene KL and Alzheimer disease.